Abstract:Hyperbilirubinemia generally relates to an elevated bilirubin level in the blood and is usually an indication of a disease of the blood, liver, or biliary tract. Hemo‐perfusion using synthetic resins as sorbents has been one of the ways to reduce bilirubin. In this study, chitosan, a natural polysaccharide having structural characteristics similar to glycosaminoglycans and which is nontoxic and biocompatible, has been used for bilirubin binding. Several layers of poly‐l‐lysine have been coated covalently onto chitosan beads, using N2plasma and carbodiimide treatments. Such surface‐modified chitosan beads exhibited high binding affinities for bilirubin (1.13 ± 0.18 mg/g beads) in aqueous phosphate buffer solutions at 4°C in relation to activated charcoal (0.74 ± 0.2 mg/g). The poly‐lysine‐coated resins have been reported to have an improved binding affinity for bilirubin over cholestyramine. It seems that the surface‐immobilized polylysine has an increased bilirubin binding affinity and is highly stable. The binding capacity is proportional to the amount of polylysine bonded to the chitosan beads. The hemolytic potential of all modified beads is compatible with polystyrene control tubes. Studies were also performed against albumin as proof of specificity toward bilirubin binding. The albumin‐coated beads have shown the highest blood compatibility and selectivity over the other modified beads. However, it appears that polylysine‐modified chitosan may be an excellent sorbent system for hemoperfusion due to its high binding affinity, capacity, and blood compatibility. Further studies are needed to determine its behavior under
展开▼
